27.46
-0.74 (-2.62%)
-0.74 (-2.62%)
Upgrade to Real-Time
Afterhours (Closed)
Low
17.43
High
47.61
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.74 | -2.62% | 27.46 | 16:44:51 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 27.86 | 27.35 | 28.47 | 27.46 | 28.20 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 25.05 | 28.70 | 3.65 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,016 | 65,123 | $ 27.83 | $ 1,812,542 | - | 17.43 - 47.61 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:02 | 79 | $ 27.46 | USD |
Period:
Draw Mode:
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 966.86M | 35.21M | 20.12M | $ - | $ - | -0.49 | -25.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 54.35k | 0.50% |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 28.50 | 29.11 | 26.535 | 27.93 | 232,315 | -1.04 | -3.65% |
| 1 Month | 27.74 | 29.6734 | 26.535 | 28.18 | 165,379 | -0.28 | -1.01% |
| 3 Months | 25.99 | 29.6734 | 23.42 | 25.82 | 215,083 | 1.47 | 5.66% |
| 6 Months | 36.22 | 37.87 | 17.43 | 25.24 | 355,599 | -8.76 | -24.19% |
| 1 Year | 23.47 | 47.61 | 17.43 | 27.78 | 271,152 | 3.99 | 17.0% |
| 3 Years | 19.70 | 47.61 | 17.43 | 27.67 | 266,468 | 7.76 | 39.39% |
| 5 Years | 19.70 | 47.61 | 17.43 | 27.67 | 266,468 | 7.76 | 39.39% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
